Yunnan Hongxiang Yixintang Net Assets

Latest as of June 2026: CN¥7.61 Billion CNY ≈ $1.11 Billion USD

Yunnan Hongxiang Yixintang net assets. Based on the latest financial reports, Yunnan Hongxiang Yixintang (002727) has net assets worth CN¥7.61 Billion CNY (≈ $1.11 Billion USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥15.31 Billion ≈ $2.24 Billion USD) and total liabilities (CN¥7.70 Billion ≈ $1.13 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Yunnan Hongxiang Yixintang growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥7.61 Billion
% of Total Assets 49.7%
Annual Growth Rate 23.26%
5-Year Change 11.76%
10-Year Change 198.52%
Growth Volatility 28.61

Net Assets of Yunnan Hongxiang Yixintang (2009–2025)

Net assets of Yunnan Hongxiang Yixintang from 2009 to 2025. This chart illustrates how Yunnan Hongxiang Yixintang's net assets have evolved over time, based on quarterly financial data. See 002727 net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Yunnan Hongxiang Yixintang (2009–2025)

The table below shows the annual net assets of Yunnan Hongxiang Yixintang from 2009 to 2025. For live market cap and overall valuation, see 002727 market cap overview.

Year Net Assets Change
2025-12-31 CN¥7.46 Billion
≈ $1.09 Billion
-2.56%
2024-12-31 CN¥7.65 Billion
≈ $1.12 Billion
-2.84%
2023-12-31 CN¥7.88 Billion
≈ $1.15 Billion
+4.64%
2022-12-31 CN¥7.53 Billion
≈ $1.10 Billion
+12.81%
2021-12-31 CN¥6.67 Billion
≈ $976.40 Million
+15.43%
2020-12-31 CN¥5.78 Billion
≈ $845.87 Million
+25.77%
2019-12-31 CN¥4.60 Billion
≈ $672.56 Million
+13.50%
2018-12-31 CN¥4.05 Billion
≈ $592.57 Million
+9.63%
2017-12-31 CN¥3.69 Billion
≈ $540.54 Million
+47.87%
2016-12-31 CN¥2.50 Billion
≈ $365.55 Million
+9.91%
2015-12-31 CN¥2.27 Billion
≈ $332.61 Million
+9.14%
2014-12-31 CN¥2.08 Billion
≈ $304.77 Million
+98.33%
2013-12-31 CN¥1.05 Billion
≈ $153.67 Million
+29.52%
2012-12-31 CN¥810.77 Million
≈ $118.64 Million
+28.94%
2011-12-31 CN¥628.80 Million
≈ $92.01 Million
+26.41%
2010-12-31 CN¥497.43 Million
≈ $72.79 Million
+89.30%
2009-12-31 CN¥262.78 Million
≈ $38.45 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Yunnan Hongxiang Yixintang's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 9022.4% over the analyzed period, indicating profitable operations and earnings retention.

Yunnan Hongxiang Yixintang Net Assets Breakdown (December 2025)

Yunnan Hongxiang Yixintang net assets breakdown by equity component as of December 2025.

Component Amount Percentage
Retained Earnings CN¥4.50 Billion 61.59%
Other Components CN¥2.80 Billion 38.41%
Total Equity CN¥7.30 Billion 100.00%

Yunnan Hongxiang Yixintang Competitors by Market Cap

The table below lists competitors of Yunnan Hongxiang Yixintang ranked by their market capitalization.

Company Market Cap
Donnelley Financial Solutions Inc
NYSE:DFIN
$1.16 Billion
PowerTECH Co. Ltd. A
SHE:301369
$1.17 Billion
Wolfspeed, Inc.
NYSE:WOLF
$1.17 Billion
Asian Star Anchor Chain Co Ltd Jiangsu
SHG:601890
$1.17 Billion
Hunan Zhongke Electric
SHE:300035
$1.16 Billion
Newag S.A.
WAR:NWG
$1.16 Billion
Shenzhen Desay Battery Technology Co Ltd
SHE:000049
$1.16 Billion
Shelly Group SE
XETRA:SLYG
$1.16 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Yunnan Hongxiang Yixintang's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 7,491,014,022 to 7,303,470,419, a change of -187,543,603 (-2.5%).
  • Net income of 263,432,452 contributed positively to equity growth.
  • Dividend payments of 304,891,343 reduced retained earnings.
  • Other comprehensive income decreased equity by 366,768,341.
  • Other factors increased equity by 220,683,630.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥263.43 Million +3.61%
Dividends Paid CN¥304.89 Million -4.17%
Other Comprehensive Income CN¥-366.77 Million -5.02%
Other Changes CN¥220.68 Million +3.02%
Total Change CN¥- -2.50%

Book Value vs Market Value Analysis

This analysis compares Yunnan Hongxiang Yixintang's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.09x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 18.49x to 1.09x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2009-12-31 CN¥0.73 CN¥13.59 x
2010-12-31 CN¥1.32 CN¥13.59 x
2011-12-31 CN¥1.60 CN¥13.59 x
2012-12-31 CN¥2.07 CN¥13.59 x
2013-12-31 CN¥2.68 CN¥13.59 x
2014-12-31 CN¥4.57 CN¥13.59 x
2015-12-31 CN¥4.37 CN¥13.59 x
2016-12-31 CN¥4.80 CN¥13.59 x
2017-12-31 CN¥7.10 CN¥13.59 x
2018-12-31 CN¥7.12 CN¥13.59 x
2019-12-31 CN¥8.09 CN¥13.59 x
2020-12-31 CN¥10.06 CN¥13.59 x
2021-12-31 CN¥11.11 CN¥13.59 x
2022-12-31 CN¥12.48 CN¥13.59 x
2023-12-31 CN¥12.98 CN¥13.59 x
2024-12-31 CN¥12.65 CN¥13.59 x
2025-12-31 CN¥12.47 CN¥13.59 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Yunnan Hongxiang Yixintang utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 3.61%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.52%
  • • Asset Turnover: 1.11x
  • • Equity Multiplier: 2.14x
  • Recent ROE (3.61%) is below the historical average (15.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2009 32.86% 5.83% 2.12x 2.65x CN¥59.03 Million
2010 21.03% 5.56% 1.67x 2.26x CN¥54.00 Million
2011 21.59% 6.07% 1.70x 2.10x CN¥72.33 Million
2012 22.64% 6.42% 1.86x 1.89x CN¥101.91 Million
2013 23.00% 6.79% 1.71x 1.98x CN¥136.13 Million
2014 14.28% 6.71% 1.51x 1.41x CN¥89.04 Million
2015 15.23% 6.51% 1.27x 1.84x CN¥118.96 Million
2016 14.16% 5.65% 1.04x 2.41x CN¥103.74 Million
2017 11.44% 5.45% 1.08x 1.93x CN¥53.32 Million
2018 12.88% 5.68% 1.25x 1.82x CN¥116.51 Million
2019 13.14% 5.76% 1.32x 1.73x CN¥144.43 Million
2020 13.70% 6.24% 1.36x 1.62x CN¥213.42 Million
2021 14.01% 6.32% 1.02x 2.18x CN¥263.81 Million
2022 13.60% 5.79% 1.08x 2.18x CN¥267.38 Million
2023 7.09% 3.16% 1.04x 2.15x CN¥-225.16 Million
2024 1.52% 0.63% 1.07x 2.25x CN¥-634.96 Million
2025 3.61% 1.52% 1.11x 2.14x CN¥-466.91 Million

Industry Comparison

This section compares Yunnan Hongxiang Yixintang's net assets metrics with peer companies in the Pharmaceutical Retailers industry.

Industry Context

  • Industry: Pharmaceutical Retailers
  • Average net assets among peers: $1,927,797,735
  • Average return on equity (ROE) among peers: 10.24%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Yunnan Hongxiang Yixintang (002727) CN¥7.61 Billion 32.86% 1.01x $1.16 Billion
Cachet Pharmaceutical Co Ltd (002462) $1.09 Billion 5.84% 0.45x $457.17 Million
Luyan Pharma Co Ltd (002788) $3.19 Billion 10.83% 2.96x $543.51 Million
Ji Yao Holding Group Co Ltd (300108) $398.00 Million 6.82% 0.17x $20.47 Million
ShuYu Civilian Pharmacy Corp. Ltd. (301017) $1.53 Billion 14.14% 1.27x $836.28 Million
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) $1.85 Billion 1.44% 2.34x $260.89 Million
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) $947.01 Million 16.98% 1.72x $814.21 Million
Shanghai No1 Pharmacy Co Ltd (600833) $736.00 Million 6.25% 0.61x $307.84 Million
Dashenlin Pharm Grp Co Ltd (603233) $2.80 Billion 16.95% 1.08x $3.49 Billion
Laobaixing Pharmacy (603883) $4.81 Billion 12.92% 1.35x $1.67 Billion

About Yunnan Hongxiang Yixintang

SHE:002727 China Pharmaceutical Retailers
Market Cap
$1.16 Billion
CN¥7.96 Billion CNY
Market Cap Rank
#7971 Global
#1735 in China
Share Price
CN¥13.59
Change (1 day)
+0.37%
52-Week Range
CN¥9.59 - CN¥14.38
All Time High
CN¥45.43
About

Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline pro… Read more